N~2~-[(2S)-2-(3,5-Difluorophenyl)-2-hydroxyacetyl]-N-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide(CAS: 209984-57-6)

The compound is subject to various regulatory guidelines including the GHS (Globally Harmonized System of Classification and Labeling of Chemicals), REACH (Registration, Evaluation, Authorization and Restriction of Chemicals) regulations, as well as FDA and EPA requirements. Companies must comply with these standards for handling, storage, and transportation.

There are several alternatives that can be used in synthesis, including analogs and isomers such as 3,5-Difluorophenyl derivatives and other azepinone derivatives. Common alternative reagents include [alternative reagents] which can provide similar functionalities in a more accessible manner.

The market trend for this compound is showing steady growth, driven by its applications in various industries such as pharmaceuticals and materials science. Research is focusing on its potential in drug discovery and development, with a particular interest in its role as a potential therapeutic agent.

Waste containing this compound should be collected and disposed of in accordance with local and international regulations. Proper handling includes neutralizing any acidic or basic components, ensuring proper containment to prevent environmental contamination, and disposing of the waste through professional waste disposal services or incineration facilities.